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Abstract 39 
In lean individuals, acute aerobic exercise is reported to transiently suppress sensations of appetite, 40 
suppress blood-concentrations of acylated ghrelin (AG) and increase glucagon-like peptide-1 (GLP-1) 41 
and peptide-YY (PYY). Findings in overweight/obese individuals have yet to be synthesised.    42 
In this systematic review and meta-analysis, we quantified the effects acute exercise has on AG, total 43 
PYY and GLP-1 in overweight/obese individuals. The potential for body mass index (BMI) to act as a 44 
moderator for AG was also explored.  45 
Six published studies (73 participants, 78% male, mean BMI: 30.6 kg.m-2) met the inclusion criteria. 46 
Standardised mean differences (SMD) and standard errors were extracted for AG, total PYY and 47 
GLP-1 concentrations in control and exercise trials and synthesised using a random effects meta-48 
analysis model. BMI was the predictor in a meta-regression for AG. 49 
Exercise moderately suppressed AG area-under-the-curve concentrations (pooled SMD -0.34, 95%CI: 50 
-0.53 to -0.15). The magnitude of this reduction was greater for higher mean BMIs (pooled meta-51 
regression slope: -0.04 SMD/kg.m-2 (95%CI: -0.07 to 0.00)). Trivial SMDs were obtained for total PYY 52 
(0.10, 95%CI: -0.13 to 0.31) and GLP-1 (-0.03, 95%CI: -0.18 to 0.13).  53 
This indicates that exercise in overweight/obese individuals moderately alters AG in a direction that 54 
could be associated with decreased hunger and energy intake. (PROSPERO registration: 55 
CRD42014006265). 56 
 57 
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Introduction 69 
Adults with a body mass index (BMI) of equal to or greater than 25 kg.m-2 are classified as 70 
overweight, whilst those with a BMI equal to or greater than 30 kg.m-2 are classified as obese [1]. In 71 
2008, it was estimated that 1.4 billion adults were overweight worldwide. Of these, 200 million men 72 
and nearly 300 million women were obese [1]. Obesity is associated with an increased risk of type 2 73 
diabetes, coronary heart disease, some types of cancer, as well as strokes [2]. The health risks and 74 
financial burden associated with overweight and obesity are causes for concern. Governments are 75 
developing schemes and guidelines to help counter overweight and obesity. Alongside limiting energy 76 
intake, individuals are advised to take part in regular physical activity. In the UK, healthy adults are 77 
advised to perform at least 150 min of moderate intensity aerobic activity per week, and to combine 78 
this with muscle strengthening exercise twice a week [3].   79 
‘Exercise induced anorexia’ was a term coined in 1994 by King and colleagues, to describe 80 
the condition where appetite is supressed after acute exercise [4]. King et al. [4] showed that appetite 81 
was temporarily suppressed during and after high intensity exercise in lean healthy males. 82 
Subsequent researchers confirmed these earlier findings [5-9]. At rest, feelings of hunger are 83 
mediated by gut hormones such as acylated ghrelin, peptide-YY (PYY) and glucagon-like peptide-1 84 
(GLP-1) [10-12]. It has been hypothesised that ‘exercise induced anorexia’ is mediated by altered 85 
concentrations of these hormones. For example, acylated ghrelin (an appetite stimulating hormone) 86 
has been found to be suppressed after vigorous exercise [6, 9, 13]. In contrast, circulating 87 
concentrations of PYY and GLP-1 (satiety hormones), have been shown to increase after exercise in 88 
healthy lean adults [6, 9, 13]. Researchers have also examined the effects that exercise has on 89 
energy intake after exercise. The majority of studies indicate that individuals do not compensate for 90 
the energy expended during exercise in the immediate hours after exercise [14]. Therefore these 91 
individuals are in an energy deficit, and if maintained over time this could result in weight loss.  92 
Most studies on exercise and appetite regulation involve crossover designs and relatively 93 
small sample sizes. Meta-analyses can be useful to quantify the effects of an intervention with greater 94 
precision from a pooled estimate. A standardised mean difference (SMD) is often reported. Recently, 95 
the effects of acute exercise on appetite regulatory hormones were examined in lean, 96 
overweight/obese individuals [15]. It was concluded that an acute bout of exercise suppresses 97 
acylated ghrelin (SMD: 0.20) and increases PYY (SMD: 0.24), GLP-1 (SMD: 0.28) and pancreatic 98 
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polypeptide (SMD: 0.50). Of the 25 studies included in this review, only two involved 99 
overweight/obese individuals. Clearly, there are fewer studies on overweight/obese individuals and no 100 
previous systematic review and meta-analysis has been undertaken on this population. Such a review 101 
would capture new studies involving overweight/obese individuals, and clarify if they respond in a 102 
similar way to their lean counterparts. This in turn could enhance understanding of the role exercise 103 
plays in weight maintenance and control. Therefore, we aimed to synthesise this evidence from 104 
studies investigating acute exercise bouts and circulating concentrations of acylated ghrelin, total PYY 105 
and total GLP-1, measured in overweight/obese participants. 106 
 107 
Methods 108 
Data source 109 
A systematic review of peer-reviewed studies was undertaken comparing concentrations of 110 
appetite regulatory hormones, quantified as an area under the curve (AUC). The review was 111 
registered with the PROSPERO database (CRD42014006265). 112 
The literature search was conducted by an information specialist (JA) using commonly-used 113 
research databases (Applied Social Sciences Index and Abstracts (ASSIA), Campbell Collaboration, 114 
Centre for Review and Dissemination, Database of Promoting Health Effectiveness Reviews 115 
(DoPHER), Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of 116 
Systematic Reviews, Cochrane Methodology Register, Database of Abstracts of Reviews or Effects 117 
(DARE), EMBASE, NHS Economic Evaluation Database (NHS EED), PROSPERO, PubMed, 118 
PsycINFO MEDLINE (Ovid), Sports Discus, SCOPUS, Web of Knowledge and CINAHL). These 119 
databases were searched in January 2014 with an update search in June 2014 and October 2016. 120 
Keyword searches were performed for ‘exercise’, ‘physical activity’, ‘energy expenditure’, ‘energy 121 
intake’, ‘appetite’, ‘hunger’, ‘food intake’, ‘ghrelin’, ‘acylated ghrelin’, ‘total ghrelin’, ‘acyl ghrelin’, 122 
‘peptide YY’, ‘PYY’, ‘peptide YY3-36’, ‘PYY3-36’, ‘total PYY’, ‘glucagon-like peptide-1’, ‘GLP-1’, ‘active 123 
GLP-1’, ‘GLP-1(7-36)’, ‘GLP-1(9-36)’, ‘obese’, ‘overweight’, and ‘appetite hormones’. Details of the 124 
search strategy are provided in the supplementary material. 125 
Inclusion criteria 126 
For inclusion, studies were required to meet the following criteria: participants in the study 127 
were overweight/obese adults, with no history of diabetes, gastrointestinal, inflammatory, metabolic, 128 
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cardiovascular or psychological disease; in addition participants were required to be non-smokers. 129 
Study selection criteria were not limited by the duration or observation period post-exercise. To 130 
maximise search sensitivity, there were also no limitations on the intensity, duration or modality of the 131 
acute exercise bout.  132 
All studies were required to have a control condition which was completed by the same 133 
participants who completed the exercise condition. The control condition was required to be identical 134 
to that of the exercise condition, minus the exercise bout.  135 
Since the interventions were exercise bouts, investigators were not blinded. Studies were 136 
included if they were published in peer-reviewed journals, or were available in conference 137 
proceedings, theses or dissertations. A broad range of sources for study inclusion where chosen to 138 
minimize the risk of small study effects, which can occur if only published studies are included.  139 
Exclusion criteria 140 
Studies were excluded if they did not measure acylated ghrelin, total PYY or total GLP-1 141 
responses to an exercise bout in overweight/obese individuals. Studies were also excluded if they did 142 
not include a control trial.   143 
Study selection 144 
Two members of the research team (JAD and KD) independently selected the studies for 145 
inclusion in the meta-analysis and later compared notes to reach a mutual consensus. Potential 146 
studies were identified by examining the abstracts and full-text copies were obtained if they met the 147 
initial criteria of evaluating appetite hormone changes in response to an acute exercise bout. In the 148 
original literature search conducted in January 2014, five studies met the inclusion criteria. Two 149 
update searches conducted in June 2014 and October 2016, identified one further study. Together six 150 
studies met the inclusion criteria for the current meta-analysis (Figure 1). 151 
Data synthesis 152 
Included studies were assessed for quality and validity independently by two authors (JAD 153 
and KD), using established criteria (Physiotherapy Evidence Database [PEDro], 154 
http://www.pedro.org.au/english/downloads/pedro%20scale/). Data on the study methods, sample 155 
size, participant characteristics, blood analytical methods, exercise intervention information, and 156 
hormone (pmol.L-1 h-1, pg.mL-1 h-1, µU.mL-1 h-1) and appetite AUC data were extracted for both control 157 
and exercise conditions by one author (JAD) into a computerised spreadsheet. Data entry was 158 
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checked by one other author (KD), and discrepancies discussed and checked again. If standard error 159 
of the mean (SEM) was reported, these were converted to standard deviations [16].  160 
Meta-analysis procedures 161 
Comprehensive Meta-Analysis software (Version 2.2.064; Biostat, Englewood, NJ, USA), was 162 
used to conduct a random effects (DerSimonian-Laird inverse variance approach) meta-analysis of 163 
the mean difference in acylated ghrelin, total PYY and total GLP-1 during control and exercise trials 164 
[16]. The inputted data included sample sizes, AUCs for the control and exercise conditions (with their 165 
respective standard deviations) and an imputed correlation coefficient to take into account the fact 166 
that all studies were crossover in nature. These correlation coefficients were estimated from prior 167 
reliability studies in our laboratory and were as follows; acylated ghrelin; r=0.93, total PYY: r=0.71 and 168 
GLP-1: r=0.94. The software calculated the pooled standardised difference in means to determine the 169 
effect size [17]. All data are presented as means (95% confidence interval). 170 
We interpreted standardised mean difference (SMD) values of <0.2 as trivial, 0.2-0.3 as 171 
small, 0.4-0.8 as moderate and >0.8 as large [18]. A negative effect size indicates that exercise was 172 
associated with decreased hormone concentrations, while a positive effect size indicates that 173 
hormone concentrations increased with exercise [19]. Heterogeneity was explored using a Q-test, I-174 
square statistic and the tau-squared statistic. An I-square statistic >50% was deemed to be indicative 175 
of substantial heterogeneity.  176 
Meta-regression analyses for BMI of acylated ghrelin AUC between exercise and control conditions 177 
BMI was used as a moderator in a meta-regression analysis (methods-of-moments model), to 178 
determine if BMI could explain the variation in effect size values seen between studies for acylated 179 
ghrelin concentrations [17]. Mean BMIs were pooled from studies collected in the current review 180 
together with those reported for lean individuals in a recent review by Schubert et al. [15]. Mean BMI 181 
was included as a moderating variable, as a negative association exists between study mean BMI 182 
and acylated ghrelin concentrations [29]. This analysis was only performed for acylated ghrelin as 183 
there were not enough studies (N < 3) reporting data for total PYY or total GLP-1 to obtain sufficiently-184 
precise and meaningful estimations of meta-regression slope. 185 
Exploration of small study effects 186 
Small study effects were explored with a funnel plot of standard difference in means vs 187 
associated standard errors [20] and by quantifying Egger’s linear regression intercept. A large and 188 
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statistically significant Egger’s statistic indicates the presence of a small study effect. This analysis 189 
was only performed for acylated ghrelin as there were not enough studies reporting data for a precise 190 
exploration of total PYY and total GLP-1. 191 
 192 
Results 193 
Overview 194 
Six studies involving a total of 73 participants met the inclusion criteria for the meta-analysis. 195 
All of these had been published (or accepted for publication) in peer-reviewed scientific journals. The 196 
experimental trials in each study lasted between 2 and 3 h, with exercise conducted in a fasted 197 
condition or following a standardised breakfast. Three studies included standardised meals before the 198 
exercise bout [13, 21, 22] and four studies included ad libitum meals after the exercise bout [13, 21- 199 
23]. Blood samples were collected at regular intervals throughout all trials.  200 
The included studies are summarised in Table 1. The majority of studies recruited participants 201 
of the same sex. One study recruited both males and females [21]. Two of the studies involved more 202 
than one exercise intensity trial [21, 23], and are reported in the analysis as “multiple trials”. 203 
Accounting for these, the total number of trials is 10, each including one control and one exercise 204 
condition. Six studies (10 trials) reported acylated ghrelin AUC data, two studies (four trials) reported 205 
total PYY AUC data and two studies (four trials) reported total GLP-1 AUC data. Of the 10 trials, one 206 
used treadmill walking as the mode of exercise, two used treadmill running and seven used a cycle 207 
ergometer. The mean PEDro score for the six studies was 6 ± 0, rating all studies to have “good” 208 
methodological quality. 209 
Participant demographics and exercise intervention characteristics 210 
Of the 73 participants included in the meta-analysis, 57 were men (78%) and 16 were women 211 
(22%). BMI values of the 73 participants ranged from 27.7 to 32.7 kg.m-2 (mean 30.6 kg.m-2). Four 212 
studies used exercise which was aerobic in nature [13, 22, 23, 25], and two compared aerobic 213 
exercise with two variations of high intensity exercise [21, 23]. The exercise interventions lasted 214 
between 9 and 60 min (mean 34 min), and exercise intensity was set between 50 and 65% VO2 peak 215 
(mean 58% VO2 peak, N = 6) or 72.5 and 87.5% HRmax (mean 79.4 % HRmax, N = 4). Between 7 and 216 
19 participants took part in each study (mean 12 participants) (see Table 1 for summaries of study 217 
protocols). 218 
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Meta-analysis 219 
Individual study statistics and results for both trials including overweight/obese subjects and 220 
lean subjects are summarised in the supplementary material (Tables S1 to S4). 221 
Effect size and moderator variable for acylated ghrelin AUC analysis 222 
In overweight/obese individuals there was a statistically significant moderate suppression in 223 
mean acylated ghrelin AUC concentrations in exercise trials compared with resting trials (pooled 224 
effect size -0.34, 95% confidence interval -0.533 to -0.146; N = 10; P < 0.001; Figure 2). 225 
Heterogeneity was found to be high between these studies (I2 = 87.7%; Q = 73.4, T2 = 0.084, df = 9). 226 
For this reason a random effects model was chosen to conduct the meta-analyses [26]. 227 
Sensitivity analysis showed that the study by Gholipour et al. [24] increased the effect size of 228 
exercise on mean acylated ghrelin AUC concentrations. The removal of this study decreased the 229 
pooled effect size to -0.23 (95% confidence interval -0.35 to -0.11, P < 0.001).230 
When data from lean individuals were included into the meta analysis, with that of the 231 
previously-reported overweight and obese individuals the pooled standardised effect size of exercise 232 
on acylated ghrelin AUC data was reduced to -0.215, 95% confidence interval -0.324 to -0.105; N = 233 
33; P <0.001). 234 
Using BMI as a moderator in a meta-regression model, a higher mean BMI was associated 235 
with a greater exercise induced suppression of acylated ghrelin AUC concentration. The slope of 236 
regression for BMI was shallow, but significantly negative (95% confidence interval -0.073 to -0.010; P 237 
= 0.044; Figure 3). The standardised reduction in acylated ghrelin for exercise vs control conditions 238 
was found to be 0.037 units more marked for every 1 kg.m-2 increase seen in BMI. Including baseline 239 
acylated ghrelin concentrations and BMI into a multiple meta-regression model had little effect on the 240 
results; the slope of regression became slightly more negative so that the standardised reduction in 241 
acylated ghrelin for exercise vs control was 0.040 units more marked for every 1 kg.m-2 increase in 242 
BMI (95% confidence interval -0.080 to -0.010; P = 0.020). 243 
Inspection of the funnel plot (see Figure 4) and Egger’s regression intercept revealed that there was 244 
little evidence of small study effects (intercept = -3.647, 95% confidence interval -9.080 to 1.785, P = 245 
0.264).  246 
 247 
 248 
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Effect size for total PYY AUC analysis  249 
In overweight/obese individuals there was a trivial mean effect of exercise on total PYY 250 
(pooled effect size 0.099, 95% confidence interval -0.133 to 0.311; N = 4; Figure 5), and this was not 251 
significantly different from zero (P = 0.404). Heterogeneity was found to be low between these studies 252 
(I2 = 24.17%; Q = 3.96, T2 = 0.014, df = 3). 253 
Effect size and moderator variable for total GLP-1 AUC analysis 254 
In overweight/obese individuals there was a trivial mean effect of exercise on GLP-1 (Pooled 255 
effect size -0.026, 95% confidence interval -0.184 to 0.133; N = 4; Figure 6), and this was not 256 
significantly different from zero (P = 0.749). Heterogeneity was found to be high between these 257 
studies (I2 = 65.7%; Q = 8.74, T2 = 0.017, df = 3).  258 
 259 
Discussion 260 
Understanding the responses of appetite regulatory hormones to exercise and consequently 261 
the effect they may have on energy intake and appetite could enhance understanding of the role of 262 
exercise in weight control. The purpose of this review was to examine the concentration changes of 263 
acylated ghrelin, total PYY and total GLP-1 after acute exercise in overweight/obese individuals. We 264 
found acylated ghrelin to be moderately suppressed by acute exercise, whilst there were trivial effects 265 
of exercise on total PYY and total GLP-1. Ghrelin is an appetite-stimulating hormone [10] and our 266 
results suggest that exercise in overweight/obese individuals alters acylated ghrelin in a direction that 267 
would be associated with decreased hunger and energy intake. We can only speculate the effects 268 
ghrelin has on appetite and food intake as not all studies included these measures in their protocol. 269 
Future research should examine energy intake in addition to appetite and appetite regulatory 270 
hormone responses to clarify this assumption. 271 
The results of the current review appear to mirror those of lean individuals. In a recent review, 272 
lean individuals showed a small reduction in acylated ghrelin after exercise, whilst total PYY and total 273 
GLP-1 showed small increases [15]. Our findings suggest that overweight/obese individuals show 274 
broadly similar appetite hormone responses to exercise in lean individuals, in such a direction that 275 
could alter energy intake and achieve weight loss if sustained over prolonged periods of time. Again, 276 
this can only be speculated as the studies included in both the review by Schubert et al. [15] and the 277 
current review were acute in nature. 278 
10 
 
The present meta-regression demonstrated greater exercise-induced suppression of acylated 279 
ghrelin as BMI increased. Although overweight/obese individuals have shown a moderate 280 
suppression of acylated ghrelin after exercise, this suppression becomes more prominent as BMI 281 
increases from 27.7 to 32.7 kg.m-2. This finding differed from that of Schubert et al. [15], where BMI 282 
was shown to have no influence on appetite regulatory hormones. Schubert [15] included 23 studies 283 
examining responses of lean individuals and two studies with overweight/obese individuals. The 284 
inclusion of six, rather than two, studies with overweight/obese individuals in the present meta-285 
regression may explain the differences found between the two reviews. 286 
The current review found overweight/obese individuals to express a moderate reduction in 287 
acylated ghrelin during exercising conditions. Large variations in fasting and postprandial ghrelin 288 
concentrations between individuals make it difficult to establish the clinical relevance that exercise 289 
has on this hormone. In lean individuals circulating concentrations of acylated ghrelin  in the range of 290 
40-67 pg/mL may be expected in fasting conditions [27], with obese individuals expressing lower 291 
concentrations [28, 29]. We attempted to control for differences in baseline levels of acylated ghrelin 292 
between studies by accounting for fasting values observed in resting trials. This had negligible 293 
influence on the relationship between increased BMI and acylated ghrelin. 294 
The current review found three studies that examined the acute effects of exercise on 295 
appetite regulatory hormones in males, two studies in females and one including both males and 296 
females. Due to the limited number of studies in this review no conclusions can be drawn upon the 297 
effect of exercise and sex on appetite regulatory hormones. It has been hypothesised that exercise 298 
could influence acylated ghrelin differently in obese males and females. In one study, after four days 299 
of consecutive exercise females experienced an increase in acylated ghrelin, whereas males showed 300 
no change [30]. This suggests that females may be prone to increasing energy intake after exercise 301 
training. However, after acute exercise lean individuals have shown no sex difference in responses of 302 
PYY3-36 or acylated ghrelin [31]. Similar relative energy intakes were observed in males and females, 303 
suggesting that acute exercise is equally effective for both sexes. Future research is required to 304 
understand and compare the responses of males and females. 305 
The current review has several limitations. First, only six studies were identified as relevant 306 
following our literature searches. We recognise that meta-analyses are not immune from statistical 307 
power-related issues, and that the pooling of data from such a small number of studies may still 308 
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provide relatively low statistical precision (wide confidence interval for pooled effect). For example, 309 
despite finding substantial heterogeneity amongst studies in which ghrelin and GLP-1 were 310 
measured, precise analyses such as one for the presence of outliers could not be performed due to 311 
the small number of studies. We restricted our search to acute exercise trials, further reviews should 312 
examine the effects of repeated bouts of exercise and exercise training on appetite regulatory 313 
hormones in overweight/obese individuals although at present the literature on this aspect is very 314 
limited. The longest trial length in the current review was 3 h, future research should examine what 315 
happens to this population later on in the exercising day. Despite trials only lasting 2-3 h protocols 316 
differed widely between studies, potentially confounding appetite regulatory AUC estimations. 317 
Specifically, the timing of exercise and meal provision within the study protocol. AUC calculations 318 
were made over the duration of each trial, irrespective of when exercise occurred. The inclusion of 319 
rest periods prior to exercise into AUC calculations could potentially underestimate the effect of 320 
exercise on hormone responses. Additionally, studies differed by exercising participants in both fasted 321 
and fed states. Further still, studies varied in meal provision (standardised, ad libitum, or no meal) 322 
after exercise. Together these could further cofound the study of hormonal responses to exercise. We 323 
meta-regressed the SMD in acylated ghrelin vs. study mean BMI. Such study-level explorations of 324 
potential moderators of effect size should be interpreted with caution as within-study relationships can 325 
sometimes disagree with between-study relationships [32]. The average BMI of the participants in this 326 
review was 30.6 kg.m-2 (i.e. borderline obese), therefore we cannot generalise the findings of this 327 
review to those who fall higher into the obese or severely obese category. Despite our best efforts, we 328 
cannot guarantee that we captured all the relevant studies for this review. Finally, we cannot directly 329 
link the effects of exercise on appetite regulatory hormones to weight loss and management due to 330 
the acute nature of the studies, and the lack of consistency in studies including energy intake and 331 
appetite ratings. 332 
 333 
Conclusions  334 
An evidence synthesis of the six studies on overweight/obese individuals indicated that a 335 
moderate reduction in acylated ghrelin occurs after acute exercise. Only trivial effects of exercise 336 
were quantified for total PYY and GLP-1. 337 
 338 
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Tables 432 
Table 1. Hormone area under the curve (AUC) data for the six studies included in the meta-analysis. 433 
Study 
Participants 
Intervention 
Hormone AUC (pg.mL-1) 
Acylated Ghrelin Total PYY Total GLP-1 
N 
BMI  
(kg.m-2) 
Gholipour et al. 
(24) 
9 
(male) 
32.7 ± 0.8 
36 min treadmill run: 
10 min, 10 min, 5 min, 2 min at 65% V̇O2max, 
separated by 3 min at 3 km.h-1 
CON: 3512 ± 654 
EX: 1935 ± 302* 
NM NM 
Martins et al. 
(21) 
12  
(7 females 
and 5 
males) 
 
32.3 ± 2.7 
Cycling @ 85-90% HRmax until 250 kcal expended: 
8 s all out sprinting separated by 12 s easy pedalling 
(average duration, 18 ± 3 min) 
 
CON: 3921 ± 1318 
EX: 3315 ± 1219* 
NM 
CON: 4181 ± 1262 
EX: 4272 ± 969 
Cycling @ 70% HRmax until 250 kcal expended: 
continuous cycle (average duration, 27 ± 6 min) 
 
CON: 3921 ± 1318 
EX: 3296 ± 1058* 
NM 
CON: 4181 ± 1262 
EX: 4638 ± 1305 
Cycling @ 85-90% HRmax until 125 kcal expended: 
8 s all out sprinting separated by 12 s easy pedalling 
(average duration, 9 ± 2 min) 
CON: 3921 ± 1318 
EX: 3532 ± 1393 
NM 
CON: 4181 ± 1262 
EX: 4072 ± 1156 
Sim et al. 
(23) 
17 
(male) 
27.7 ± 1.6 
30 min continuous cycling @ 60% V̇O2peak 
 
CON: 70 ± 37 
EX: 69 ± 30 
 
CON: 85 ± 43 
EX: 87 ± 37 
NM 
30 min cycling: alternating between 60s @ 100% 
V̇O2peak and 240s @ 50% V̇O2peak 
 
CON: 70 ± 37 
EX: 62 ± 28 
CON: 85 ± 43 
EX: 83 ± 40 
30 min cycling: alternating between 15s @ 170% 
V̇O2peak and 60s @ 32% V̇O2peak 
CON: 70 ± 37 
EX: 56 ± 26 
CON: 85 ± 43 
EX: 88 ± 34 
 
Tiryaki-Sonmez et al. 
(25) 
9 
(female) 
28.3 ± 1.8 60 min running @ 53% V̇O2max 
CON: 51 ± 8 
EX: 47 ± 5 
NM NM 
Ueda et al. 
(13) 
7 
(male) 
30.0 ± 3.1 60 min cycle @ 50% V̇O2max 
CON: 15779 ± 10046 
EX: 16641 ± 10725 
CON: 393 ± 50* 
EX: 425 ± 46* 
NM 
Unick et al. 
(22) 
19  
(female) 
32.5 ± 4.3 
Walk @ 70-75% age predicted HRmax until 3.0 kcal.kg
-1 
of body weight expended 
(average energy expenditure, 354 ± 72 kcal; average 
duration 42 ± 8 min) 
CON: 6527 ± 2646 
EX: 6361 ± 3339 
NM 
CON: 211400 ± 51600 
EX: 201200 ± 49400* 
BMI; body mass index, CON; resting control trial, EX; exercise trial, GLP-1; glucagon-like peptide-1, HRmax; maximum heart rate, NA; AUC data not available, NM; not measured, PYY; peptide YY, V̇O2max; maximum oxygen 434 
uptake  435 
*Significantly different from control (P<0.05) NB Area under the curve values were calculated using hours as the unit of time in some studies and minutes as the unit of time in others.  436 
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Figure captions 437 
Figure 1. Flowchart of study selection 438 
Figure 2. Forest plot of effect sizes (means ± 95% confidence intervals [CIs]) for studies evaluating  439 
Figure 3. Univariable meta-regression for study mean BMI vs the acylated ghrelin AUC values in 440 
response to exercise in overweight and obese individuals SMD for acylated ghrelin. A negative 441 
correlation was observed which persisted even when baseline (control) mean ghrelin concentration 442 
was added as a covariate. 443 
Figure 4. Funnel plot of standard error by standard difference in means for studies evaluating the 444 
influence of acute exercise on acylated ghrelin AUC values in overweight/obese individuals. 445 
Figure 5. Forest plot of effect sizes (means ± 95% confidence intervals [CIs]) for studies evaluating 446 
the influence of acute exercise on total PYY AUC values in overweight and obese individuals. 447 
Figure 6. Forest plot of effect sizes (means ± 95 % confidence intervals [CIs]) for studies evaluating 448 
the influence of acute exercise on total GLP-1 AUC values in overweight and obese individuals.  449 
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Figure 1.  450 
57 full text articles 
excluded due to 
incomplete data and 
exclusion criteria 
718 articles identified 
through first database 
search 
22 articles identified 
through second 
database search 
499 articles after 
duplicates removed 
63 full-text articles 
assessed for eligibility  
436 articles excluded on 
basis of title and abstract 
6 studies included in 
the systematic review 
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